Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingmar Jungner

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Cancer Causes & Control : CCC|May 13, 2011
Low levels of apolipoprotein A-I and HDL are associated with risk of prostate cancer in the Swedish AMORIS studyMieke Van Hemelrijck, Göran Walldius, Ingmar Jungner, et al.
Cancer Causes & Control : CCC|June 20, 2012
Serum calcium and incident and fatal prostate cancer in the Swedish AMORIS studyMieke Van Hemelrijck, Ruben Hermans, Karl Michaelsson, et al.
European Journal of Cancer (Oxford, England : 1990)|April 14, 2011
Gamma-glutamyltransferase and risk of cancer in a cohort of 545,460 persons - the Swedish AMORIS studyMieke Van Hemelrijck, Wayel Jassem, Goran Walldius, et al.
BMC Molecular and Cell Biology|July 25, 2019
Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysisAida Santaolalla, Hans Garmo, Anita Grigoriadis, et al.
British Journal of Cancer|April 5, 2017
Serum inflammatory markers and colorectal cancer risk and survivalSundeep Ghuman, Mieke Van Hemelrijck, Hans Garmo, et al.
Plos One|August 24, 2018
Cardiovascular events in patients under age fifty with early findings of elevated lipid and glucose levels - The AMORIS studyTorbjörn Ivert, Håkan Malmström, Niklas Hammar, et al.
British Journal of Cancer|October 16, 2015
Serum lactate dehydrogenase and survival following cancer diagnosisWahyu Wulaningsih, Lars Holmberg, Hans Garmo, et al.
Oncotarget|April 19, 2017
Circulating uric acid levels and subsequent development of cancer in 493,281 individuals: findings from the AMORIS StudyAndrew Yiu, Mieke Van Hemelrijck, Hans Garmo, et al.
International Journal of Cancer|June 4, 2017
The association between individual metabolic syndrome components, primary liver cancer and cirrhosis: A study in the Swedish AMORIS cohortPaul Nderitu, Cecilia Bosco, Hans Garmo, et al.
Cancer Causes & Control : CCC|June 10, 2010
Immunoglobulin E and cancer: a meta-analysis and a large Swedish cohort studyMieke Van Hemelrijck, Hans Garmo, Elisa Binda, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Cancer Causes & Control : CCC|May 13, 2011
Low levels of apolipoprotein A-I and HDL are associated with risk of prostate cancer in the Swedish AMORIS studyMieke Van Hemelrijck, Göran Walldius, Ingmar Jungner, et al.
Cancer Causes & Control : CCC|June 20, 2012
Serum calcium and incident and fatal prostate cancer in the Swedish AMORIS studyMieke Van Hemelrijck, Ruben Hermans, Karl Michaelsson, et al.
European Journal of Cancer (Oxford, England : 1990)|April 14, 2011
Gamma-glutamyltransferase and risk of cancer in a cohort of 545,460 persons - the Swedish AMORIS studyMieke Van Hemelrijck, Wayel Jassem, Goran Walldius, et al.
BMC Molecular and Cell Biology|July 25, 2019
Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysisAida Santaolalla, Hans Garmo, Anita Grigoriadis, et al.
British Journal of Cancer|April 5, 2017
Serum inflammatory markers and colorectal cancer risk and survivalSundeep Ghuman, Mieke Van Hemelrijck, Hans Garmo, et al.
Plos One|August 24, 2018
Cardiovascular events in patients under age fifty with early findings of elevated lipid and glucose levels - The AMORIS studyTorbjörn Ivert, Håkan Malmström, Niklas Hammar, et al.
British Journal of Cancer|October 16, 2015
Serum lactate dehydrogenase and survival following cancer diagnosisWahyu Wulaningsih, Lars Holmberg, Hans Garmo, et al.
Oncotarget|April 19, 2017
Circulating uric acid levels and subsequent development of cancer in 493,281 individuals: findings from the AMORIS StudyAndrew Yiu, Mieke Van Hemelrijck, Hans Garmo, et al.
International Journal of Cancer|June 4, 2017
The association between individual metabolic syndrome components, primary liver cancer and cirrhosis: A study in the Swedish AMORIS cohortPaul Nderitu, Cecilia Bosco, Hans Garmo, et al.
Cancer Causes & Control : CCC|June 10, 2010
Immunoglobulin E and cancer: a meta-analysis and a large Swedish cohort studyMieke Van Hemelrijck, Hans Garmo, Elisa Binda, et al.
Pageof 7